Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-? assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis

You Sun Kim, Young Ho Kim, Won Ho Kim, Joo Sung Kim, Young Sook Park, Suk Kyun Yang, Byong Duk Ye, Byung Ik Jang, Sung Ae Jung, Yoon Tae Jeen, Jae Hee Cheon, Yong Sung Choi, Jai Hyun Choi, Beom Jin Kim, Chang Hwan Choi, Dong Soo Han

    Research output: Contribution to journalArticlepeer-review

    22 Citations (Scopus)

    Abstract

    Background: Differential diagnosis of Crohn's disease (CD) from intestinal tuberculosis (ITB) is challenging. Anti-Saccharomyces cerevisiae antibody (ASCA) is a specific serological marker for CD and INF-gamma assay (QuantiFERON-TB gold test, QFT) is a good supplementary diagnostic tool for ITB. We evaluated the clinical usefulness of ASCA and QFT for differential diagnosis of CD from ITB in Korean adults. Methods: A total of 147 patients suspected to have ITB or CD were prospectively enrolled from 13 hospitals. ASCA IgG and IgA serum titers were measured by ELISA, and the QFT test was also performed. Results: Thirty-two of 72 (44.4%) patients with CD were ASCA positive (titer > 25. U) compared to 10 of 75 ITB patients (13.3%) and 3 of 20 healthy controls (15%) (p< 0.01). The QFT test was positive in 7 patients with CD (9.7%) and 50 patients with ITB (66.6%) (p< 0.01). In cases which ASCA positive/QFT negative, the sensitivity, specificity, positive predictive value, and negative predictive value for the diagnosis of CD were 44.4%, 96.0%, 91.4%, and 64.3%, respectively. Conclusion: ASCA is a useful diagnostic tool for CD in Korea, where ITB is prevalent. In particular, when ASCA is combined with QFT, effective differential diagnosis of CD from ITB is possible.

    Original languageEnglish
    Pages (from-to)1527-1532
    Number of pages6
    JournalClinica Chimica Acta
    Volume412
    Issue number17-18
    DOIs
    Publication statusPublished - 2011 Aug 17

    Bibliographical note

    Funding Information:
    This study was supported by a grant of the Korea Healthcare Technology R&D Project (A080588), Ministry for Health, Welfare & Family Affairs, Republic of Korea.

    Copyright:
    Copyright 2011 Elsevier B.V., All rights reserved.

    Keywords

    • Anti-Saccharomyces cerevisiae antibody
    • Crohn's disease
    • INF-gamma assay
    • Intestinal tuberculosis

    ASJC Scopus subject areas

    • Biochemistry
    • Clinical Biochemistry
    • Biochemistry, medical

    Fingerprint

    Dive into the research topics of 'Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-? assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis'. Together they form a unique fingerprint.

    Cite this